news
A study has shown that plasmids use type IV CRISPR-Cas…
25 March 2020 | By Victoria Rees (Drug Target Review)
A study has shown that plasmids use type IV CRISPR-Cas against competing plasmids, leading the researchers to suggest the method as a novel way to tackle multi-drug resistant bacteria.